Showing results (401-410 of 468) with videos related to
Sort By:
Pageof 47
American Heart Journal|July 29, 2014
Independent data monitoring committees: preparing a path for the futureConnie N Hess, Matthew T Roe, C Michael Gibson, et al.Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.Journal of the American College of Cardiology|March 25, 2017
Potent P2Y<sub>12</sub> Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized TrialsEmily S Lau, Eugene Braunwald, Sabina A Murphy, et al.Journal of the American College of Cardiology|June 9, 2018
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based CareAbhinav Sharma, Robert A Harrington, Mark B McClellan, et al.Scientific Reports|April 12, 2020
Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity MeasurementsKristian C Becker, Lydia Coulter Kwee, Megan L Neely, et al.Biorxiv : the Preprint Server for Biology|September 10, 2024
AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmidDaphne F Chen, Leah T Roe, Yuping Li, et al.International Journal of Cardiology|February 12, 2013
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudySean van Diepen, L Kristin Newby, Renato D Lopes, et al.Health and Quality of Life Outcomes|June 14, 2021
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trialsTheresa M Coles, Adrian F Hernandez, Bryce B Reeve, et al.Journal of the American College of Cardiology|March 19, 2016
Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS TrialRenato D Lopes, Sergio Leonardi, Benjamin Neely, et al.American Heart Journal|September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trialJose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.Pageof 47